Inclusion of secondary chronic myelomonocytic leukemia and myeloproliferative disease, unclassifiable, in classification of pediatric myeloproliferative disorders.
Occhipinti
Elise
E
Correa
Hernan
H
Yu
Lolie
L
Craver
Randall
R
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D002869:Chromosome Aberrations; D002897:Chromosomes, Human, Pair 7 / Q000235:genetics*; D002999:Clone Cells; D018450:Disease Progression; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D015477:Leukemia, Myelomonocytic, Chronic / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D009196:Myeloproliferative Disorders / Q000145:classification* / Q000235:genetics / Q000628:therapy; D016609:Neoplasms, Second Primary / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D012008:Recurrence